Using a set of 19 lncRNAs which were common to all cancer cell lines but not enriched in exosomes (Table 2), we found a significant reduction (p value = 0.001) in enriched binding sites for both RBMX and ELAVL1 (Fig. 6A). The gene discussed is ELAVL1; the disease is cancer.